全球幽门螺旋桿菌非侵入性检测市场规模、份额、趋势和成长分析报告（2026-2034年）

预计到 2034 年，幽门螺旋桿菌非侵入性检测市场规模将达到 10.0301 亿美元，高于 2025 年的 6.6 亿美元，预计从 2026 年到 2034 年的复合年增长率将达到 4.76%。

受胃肠道感染疾病日益普遍以及对便捷诊断方法需求不断增长的推动，全球幽门螺旋桿菌非侵入性检测市场正稳步增长。幽门螺旋桿菌是一种会引起胃溃疡的细菌，也与某些类型的胃癌有关。呼吸检测、粪便抗原检测和血液检测等非侵入性检测方法被广泛用于诊断。

推动该市场发展的主要因素是人们对消化器官系统健康的日益关注以及对早期诊断重要性的持续认识。与内视镜检查等侵入性检查相比，非侵入性诊断测试更安全、更舒适、更易于操作，因此更受青睐。此外，诊断技术的进步也提高了测试的准确性和可靠性。

随着医疗专业人员日益重视早期检测和预防医学，非侵入性幽门螺旋桿菌检测市场预计将会扩大。医疗保健投资的增加和诊断基础设施的改善将促进先进检测方法的应用。此外，人们对胃肠道疾病认识的提高也有望推动市场成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球幽门螺旋桿菌非侵入性检测市场：按类型划分

• 市场分析、洞察与预测
• 血清学检测
• 粪便抗原检测
• 尿素呼吸检测

第五章 全球幽门螺旋桿菌非侵入性检测市场：依检测类型划分

• 市场分析、洞察与预测
• 检查室检测
• 即时检测

第六章：全球幽门螺旋桿菌非侵入性检测市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 诊所
• 诊断检查室

第七章 全球幽门螺旋桿菌非侵入性检测市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • DiaSorin SpA
  • Meridian BioscienceInc
  • Exalenz Bioscience Ltd
  • Abbott
  • Thermo Fisher Scientific
  • BiomericaInc
  • Certest Biotec SL
  • Sekisui Diagnostics
  • Coris BioConcept
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
  • Alere
  • Bio-Rad LaboratoriesInc
  • Cardinal Health
  • Fisher Scientific
  • Quidel Corporation

The Helicobacter Pylori Non-Invasive Testing Market size is expected to reach USD 1003.01 Million in 2034 from USD 660.00 Million (2025) growing at a CAGR of 4.76% during 2026-2034.

The global Helicobacter pylori non-invasive testing market is growing steadily due to the rising prevalence of gastrointestinal infections and increasing demand for convenient diagnostic methods. Helicobacter pylori is a bacterium that can cause stomach ulcers and is associated with certain types of gastric cancer. Non-invasive testing methods such as breath tests, stool antigen tests, and blood tests are widely used for diagnosis.

A major driver of this market is the increasing awareness of gastrointestinal health and the importance of early diagnosis. Non-invasive diagnostic tests are preferred because they are safer, more comfortable for patients, and easier to perform compared to invasive procedures such as endoscopy. Additionally, advancements in diagnostic technologies are improving test accuracy and reliability.

In the future, the Helicobacter pylori non-invasive testing market is expected to expand as healthcare providers emphasize early detection and preventive care. Growing healthcare investments and improved diagnostic infrastructure will support the adoption of advanced testing methods. Increasing awareness about gastrointestinal diseases is also expected to drive market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Serology Test
• Stool Antigen Test
• Urea Breath Test

By Test Type

• Laboratory-based Tests
• Point-of-Care Tests

By End-User

• Hospitals
• Clinics
• Diagnostic Laboratories

COMPANIES PROFILED

• DiaSorin SpA, Meridian Bioscience, Inc, Exalenz Bioscience Ltd, Abbott, Thermo Fisher Scientific, Biomerica, Inc, Certest Biotec SL, Sekisui Diagnostics, Coris BioConcept, Shenzhen Zhonghe Headway BioSci Tech Co, Ltd, Alere, BioRad Laboratories, Inc, Cardinal Health, Fisher Scientific, Quidel Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Serology Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Stool Antigen Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Urea Breath Test Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Laboratory-based Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Point-of-Care Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Test Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Test Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Test Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Test Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Test Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 DiaSorin S.p.A
  • 9.2.2 Meridian BioscienceInc
  • 9.2.3 Exalenz Bioscience Ltd
  • 9.2.4 Abbott
  • 9.2.5 Thermo Fisher Scientific
  • 9.2.6 BiomericaInc
  • 9.2.7 Certest Biotec S.L
  • 9.2.8 Sekisui Diagnostics
  • 9.2.9 Coris BioConcept
  • 9.2.10 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
  • 9.2.11 Alere
  • 9.2.12 Bio-Rad LaboratoriesInc
  • 9.2.13 Cardinal Health
  • 9.2.14 Fisher Scientific
  • 9.2.15 Quidel Corporation